Novo Nordisk's liraglutide may help thousands of patients. It may also cause thyroid cancer.Does a promising new class of diabetes drugs boost the risk of a rare thyroid tumor that may take decades to develop? Read at
http://www.forbes.com/2009/04/03/diabetes-liraglutide-novo-nordisk-busin...
In what could revolutionise healthcare for the rising diabetes population worldwide, scientists claimed to have developed a 15-minute non-surgical treatment that could lead to drastic weight loss and reverse the onset of the disease.The breakthrough treatment, considered a cheap and safe alternative to surgery, involves a device called EndoBarrier — a plastic sleeve that is inserted into the intestine of a patient to prevent food being absorbed into the body
Diabetes is a metabolic disorder caused when the body is unable to properly produce insulin, a hormone naturally produced by the pancreas and needed to convert sugars, starches and other food into energy and fuel for our bodies.
Kidney disease is becoming a growing problem in developing countries, caused by an explosion in cases of diabetes and high blood pressure, experts say.
The injected medication, liraglutide, is under review by the FDA to treat type 2 diabetes. In a study, three-quarters of patients on high doses of the drug lost 5% or more of their body weight.
